FDA Summary Report on Antimicrobials Sold or Distributed for Use in Food-Producing Animals

  13 December 2022

Each year, every sponsor of an approved or conditionally approved animal drug application containing an
antimicrobial active ingredient must report to the Food and Drug Administration (FDA) the amount of
each such ingredient in these drug products sold or distributed for use in food-producing animals. FDA
summarizes this information and makes it available to the public in annual summary reports. This
reporting requirement was enacted by Congress in 2008 to assist FDA in its continuing analysis of the
interactions (including antimicrobial resistance), efficacy, and safety of antimicrobials approved for use in
both humans and food-producing animals.

This summary report presents the sales and distribution data for actively marketed antimicrobial drugs
approved for use in food-producing animals by drug class, medical importance, route of administration,
indication, and dispensing status, as well as species-specific estimates, of sales and distribution from 2012
through 2021.

Download the report here

Further reading: FDA
Author(s): FDA
Healthy Animals  


Unrestricted financial support by:


Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre


EADA 2023

Emerging Antimicrobials and Diagnostics in AMR 2023

International Matchmaking Symposium EADA 2023
Amsterdam, The Netherlands
16/17 November

More information
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!